Answers are grounded in this paper and cite their sources.
Population-based analysis reports increased maternal and neonatal risks in pregnant women with haematological cancers, suggesting urgent clinical considerations.
Over the two-decade study period, we observed a significant increase in the incidence of PAHCs, with an associated higher maternal and neonatal mortality and morbidity for women with gestational HCs. Our results emphasise the critical importance of decision-making and clinical practice regarding the continuation of pregnancy and cancer management for women diagnosed with PAHCs.
No takes yet. Share an insight, caveat, or question.
Bagade et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: